The focus of obesity-management interventions should shift from percentage weight-loss targets to patient-oriented parameters such as enhancing quality of life (QoL) and function, research to be ...
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback